Zurich Switzerland 10th November Ndash Haselmeier Was Able To Successfully Grow Over The Past Few Years Allowing The Company To Carve Out A Solid Position In The Market For Medical Devices In Keeping With This Progress The Haselmeier Group Has Restructured Its Management Organisation To Ensure This Forward Momentum Continues Successfully The Company Has Introduced A Group Executive Board Tasked With Coordination And Decisionmaking For All Haselmeier Locations The Group Executive Board Will Ensure Consistent Effective Management Of The Haselmeier Sites Thereby Coordinating The Group39s Strategymr Andreas Schieber As A Supervisory Board Representative Of Medico Invest Ag Has Been Appointed To Set Up The New Organisation And Will Coordinate The Group Executive Boardthe Structure Of The New Group Executive Board Is As Followsmr Freacutedeacuteric Gabriel As Chief Strategy Officer Cso Is Responsible For Areas Of Strategy And Corporate Development Which Includes The Overall Business And Strategic Planning Strategic Innovation And Product Managementmr Volker Wirth Is Chief Business Officer Cbo Responsible For Areas Of Customerbusiness Development And Thus For The Development Of A Global Representation Key Account Management Customerproject Management And Customer Servicemr Andreas Schieber Is Acting Chief Technology Officer Cto With Dr Sascha Pohl As Deputy Responsible For Areas Of Applied Development And Thus For The Platform Management Quality Assurance And Industrialisationmr Matthias Meissner Is Chief Operations Officer Coo Responsible For The Group39s Production Sites As Well As For Its Supply Chain And Infrastructurein Addition Mr Markus Dorsch As Chief Quality Officer Cqo And Mr Siegfried Eichinger As Chief Controlling Officer Cco Will Complement The Group Executive Board In A Staff Functionthe Market Environment Regulatory Requirements And Product Needs Have Significantly Changed Over The Past Few Years Prompting Haselmeier To Expedite Its Change Process The Group Executive Board Serves As The Foundation For This Change Process It Will Open A Window Allowing Haselmeier To Gain A Stronger Foothold In The Market With New Product Innovations A More Efficient Management Of Customer And Development Projects As Well As A Modern Sustainably Safe And Superior Productionabout Haselmeierfounded In Stuttgart In 1920 Haselmeier Is One Of The Leading Designers And Manufacturers Of Injection Systems Haselmeierrsquos Devices Feature Unique Function Design And Technology And Are Marketed By Leading Pharmaceutical And Biotechnology Companies Around The World At Five Locations On Three Continents Haselmeier Develops And Produces Innovative Technology For Drug Delivery Which Enhances The Health And Daily Life Of The Patient Please Find Further Information Under Wwwhaselmeiercom
